Ann: Capital Reduction & COVID-19 Update, page-17

They definitely could have done that, without creating the overhang on the stock as it was running back up to $7. But I do appreciate the fact that the situation looked quite different before Covid.

It sounds like what we have to look forward to later year is dramatically faster delivery times with storage in the US. I imagine this could result in savings on bulk shipping and an improvement in working capital requirements with faster revenue recognition. Maybe they can even get cheap inventory financing on what's being held in the US.

But really, why are we even talking about a theoretical future capital reduction now, in the middle of high season with major brands sampling our products and a major FDA decision in the pipeline for the end of the year? Shareholders should want this mgmt team to keep investing for long-term success. The only way we can lose now is by not going big enough.